Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JNJ and other ETFs, options, and stocks.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
131,900
Employees131,900
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
131,900
Employees131,900

JNJ Key Statistics

Market cap
373.54B
Market cap373.54B
Price-Earnings ratio
25.65
Price-Earnings ratio25.65
Dividend yield
3.13%
Dividend yield3.13%
Average volume
8.38M
Average volume8.38M
High today
$157.12
High today$157.12
Low today
$154.11
Low today$154.11
Open price
$155.89
Open price$155.89
Volume
8.27M
Volume8.27M
52 Week high
$168.85
52 Week high$168.85
52 Week low
$143.13
52 Week low$143.13

JNJ News

Simply Wall St 18h
Read This Before Considering Johnson & Johnson For Its Upcoming US$1.24 Dividend

Readers hoping to buy Johnson & Johnson ( ) for its dividend will need to make their move shortly, as the stock is about to trade ex-dividend. The ex-dividend d...

Read This Before Considering Johnson & Johnson For Its Upcoming US$1.24 Dividend
Seeking Alpha 23h
Dividend Roundup: General Mills, Halliburton, Johnson & Johnson, Coca-Cola, and others

This week's dividend activity included increased payouts from Merck (MRK) and McCormick (MKC) as well as declarations from companies such as General Mills (NYSE...

Dividend Roundup: General Mills, Halliburton, Johnson & Johnson, Coca-Cola, and others
TipRanks 24h
JNJ seeks FDA approval of subcutaneous induction regimen of Tremfya

Johnson & Johnson announced the submission of a supplemental Biologics License Application to the U.S. FDA seeking approval of a subcutaneous induction regimen...

Analyst ratings

50%

of 24 ratings
Buy
50%
Hold
50%
Sell
0%

More JNJ News

TipRanks 3d
Johnson & Johnson, Merck cutting jobs in China, Bloomberg reports

Johnson & Johnson (JNJ) and Merck (MRK) are cutting jobs in China as they face growing competition from domestic rivals resulting from Beijing’s campaign to dri...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.